Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas MacCarthy

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Nucleic Acids Research|July 18, 2022
Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173A miceShanzhi Wang, Kyeryoung Lee, Stephen Gray, et al.
JCI Insight|May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient processPiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Blood|April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomasMarién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Nucleic Acids Research|July 18, 2022
Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173A miceShanzhi Wang, Kyeryoung Lee, Stephen Gray, et al.
JCI Insight|May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient processPiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Blood|April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomasMarién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
Pageof 6